Regarding E2F7, Wang et al. verified that inhibition of E2F7 expression in cells from prostate cancer cell lines dramatically decreased cell proliferation, increased cell cycle arrest in the G1 phase, and resulted in higher apoptotic rates compared with those in NC groups [29]. This evidence concerns the gene E2F7 and prostate cancer.